Home » Drug Information » Recently Approved Drugs » 1997
Medical Areas: Otolaryngology | Pediatrics/Neonatology
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Daiichi Pharmaceutical
Approval Status: Approved December 1997
Treatment Area: otitis media (ear infections)
Floxin otic (ofloxacin otic solution) has been approved for the
treatment of various forms of otitis media in pediatric and adult
patient populations. Labeling directs otitis externa pediatric
patients, one to 12 years old, to take five drops instilled into
the affected ear twice daily for ten days. Patients 12 years and
older should take ten drops twice daily for ten days.
Side effects reported during clinical trials included pruritis,
application site reaction, dizziness, earache, taste perversion,
and vertigo.
